Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam, ondansetron, and combination therapy for prevention of nausea and vomiting after strabismus surgery
IRCT20180416039326N8Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of midazolam and ondansetron in postoperative nausea and vomiting (PONV) (4 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Nausea frequency, Nausea intensity and 8 more. Started Aug 2019; status: completed.
02
Drugs
midazolamondansetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20180416039326N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180416039326N8.